Skip to content

Search

Showing results for "early lung health"

Making anaesthesia safer for kids

When kids are having surgery, the most common problem that can occur during anaesthesia is a respiratory adverse event.

Addressing challenges in gaining informed consent for a research study investigating falls in people with intellectual disability

This study describes how an informed consent process was developed for people with intellectual disability and how it is working in a current study

Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion

We found transient pDC depletion during Pneumovirus infection alone predisposed to severe bronchiolitis in early life and subsequent asthma after reinfection.

Clinical trial to examine whether “mixing” COVID-19 vaccine boosters is more effective

Top infectious disease experts in Australia will lead a clinical trial to determine whether combining different Covid-19 vaccines in the nation’s booster immunisation will increase effectiveness.

The Kids Research Institute Australia researcher a finalist for 2017 Eureka Prize

Autism researcher, Professor Andrew Whitehouse from The Kids has been named a finalist in the Eureka Prize for Emerging Leader in Science

Children with autism may benefit from app-based therapies

A The Kids Research Institute Australia study has shown that in addition to intervention with trained therapists, children with autism may benefit from app-based therapies.

Every day counts in the classroom

A recent study from The Kids Research Institute Australia has revealed some interesting facts about just how important those school attendance days are.

Chemosensitisation of medulloblastoma and pineoblastoma

Raelene Nick Endersby Gottardo BSc (Hons) PhD MBChB FRACP PhD Brainchild Fellow; Co-Head, Brain Tumour Research Head of Paediatric and Adolescent

Developing new immune based therapies for neuroblastoma

Neuroblastoma is a complex childhood cancer of the nerve cells and the most common solid tumour in children outside of the brain. The average age of diagnosis is 1-2 years and tragically 50% of children with high-risk neuroblastoma lose their battle within five years.